Beam Therapeutics Inc. BEAM

Set alert

Price alert · BEAM

All alert types
26.42 USD +0.54 +2.11%

As of Nov 3, 2:58 PM ET

Bid
26.40 × 1
Ask
26.44 × 8
25.99 Day range 27.20
20.23 52-week range 38.26
YTD
-4.71%
1 year
+8.93%
Open
26.26
Prev close
25.87
Mkt cap
2.73B
Vol
557.54K
Avg vol
1.84M
EPS
-0.68
P/E
0.00
Div yield
0.00%
More statistics
Low
25.99
High
27.20
Forward P/E
-5.45
Beta
2.22
Short ratio
13.87
Inst. own
107.81%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
25.93
200-d avg
28.14
1y target
49.38

1M chart

Chart tools
Interval

Events in this range
  • Oct 14, 2026Rating: Wedbush · Outperform → Outperform
  • Oct 15, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 28, 2026Rating: Wedbush · Outperform → Outperform
  • Oct 29, 2026Rating: Canaccord Genuity · Buy → Buy
  • Nov 3, 2026Earnings: —; estimate -1.15; surprise —%
Signals (7)
NameDateAgo
SMA: BullishOct 28, 20266 days ago
SMA: BullishOct 27, 20261 week ago
SMA: BullishOct 20, 20262 weeks ago
SMA: BearishOct 13, 20263 weeks ago
SMA: BullishOct 9, 20263 weeks ago
SMA: BearishOct 8, 20263 weeks ago
SMA: BullishOct 5, 20264 weeks ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 49.38 +87.0% upside
Target (low)
26.00
Target (mean)
49.38
Target (high)
80.00
Ratings (0m) 15 13 buy · 2 hold · 0 sell
  • Strong buy1
  • Buy12
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 15
  • 1 month ago 15
  • 2 months ago 15

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BEAM analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.17-1.28 – -1.05-1.10-6.4%9.96M+2.7%13
Next quarter-1.19-1.34 – -1.062.33-151.0%11.57M-89.9%13
Current year-4.46-4.76 – -4.24-0.81-450.1%53.22M-61.9%14
Next year-4.75-5.72 – -3.56-4.46-6.6%60.92M+14.5%14

Upgrades and downgrades

The latest rating changes

BEAM analyst upgrades and downgrades
DateFirmActionFromTo
Oct 29, 2026Canaccord GenuityMaintainedBuyBuy
Oct 28, 2026WedbushMaintainedOutperformOutperform
Oct 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
Oct 14, 2026WedbushReiteratedOutperformOutperform
Sep 9, 2026WedbushReiteratedOutperformOutperform
Aug 25, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jul 8, 2026B of A SecuritiesReiteratedBuyBuy
Jul 7, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 13, 2026BernsteinMaintainedOutperformOutperform
Mar 26, 2026CitigroupMaintainedBuyBuy
Feb 25, 2026RBC CapitalMaintainedSector PerformSector Perform
Feb 25, 2026WedbushMaintainedOutperformOutperform
Feb 20, 2026Canaccord GenuityInitiated—Buy
Jan 21, 2026BernsteinMaintainedOutperformOutperform
Jan 7, 2026UBSInitiated—Neutral
Nov 24, 2025Evercore ISI GroupInitiated—Outperform
Oct 10, 2025HC Wainwright & Co.ReiteratedBuyBuy
Oct 9, 2025JP MorganMaintainedOverweightOverweight
Sep 15, 2025HC Wainwright & Co.ReiteratedBuyBuy
Aug 6, 2025BarclaysMaintainedEqual-WeightEqual-Weight
May 7, 2025GuggenheimMaintainedBuyBuy
May 7, 2025Wells FargoMaintainedOverweightOverweight
May 7, 2025BarclaysMaintainedEqual-WeightEqual-Weight
Apr 7, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 28, 2025B of A SecuritiesUpgradeNeutralBuy
Mar 12, 2025Cantor FitzgeraldReiteratedOverweightOverweight
Mar 10, 2025ScotiabankUpgradeSector PerformSector Outperform
Mar 10, 2025Jones TradingUpgradeHoldBuy
Mar 10, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 3, 2025ScotiabankMaintainedSector PerformSector Perform